Thorough QT Study on the Effect of Therapeutic and Supratherapeutic Dosing of Givinostat in Healthy Volunteers
Eugenio Mercuri, Barry J. Byrne, Tracey Willis, John Bourke et autres
0 citationsClinical Pharmacology in Drug Development
P. Bettica
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
119Publications signalées
3577Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
Muscle Physiology and DisordersBone health and osteoporosis researchBone health and treatmentsAnxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesBone Metabolism and Diseases
Publications récentes
Trial in progress: Efficacy and safety of givinostat versus hydroxyurea in patients with polycythemia vera (GIV-IN-PV)
Alessandro Rambaldi, John Mascarenhas, P. Bettica, Maurizio Caserini et autres
0 citationsBlood
Long-Term Safety of Givinostat in Patients with Duchenne Muscular Dystrophy: Results from an Open-Label Extension Study
Kirsty Gilling, John F. Brandsema, Gyula Acsádi, N. Coceani et autres
0 citationsNeuropediatrics
70PPatient-reported outcomes from a phase 3 study of givinostat in patients with Duchenne muscular dystrophy
L. De Waele, Laura McAdam, Federica Alessi, N. Muelas et autres
0 citationsNeuromuscular Disorders
678VPVastus lateralis fat fraction is associated with functional efficacy endpoints in patients with Duchenne muscular dystrophy treated with givinostat
M. Guglieri, C. McDonald, Francesco Bellanti, Stefano Cazzaniga et autres
0 citationsNeuromuscular Disorders
687VPModeling disease progression in Duchenne muscular dystrophy: reduced decline in forced vital capacity with givinostat compared with standard of care
Catherine Laverty, E. Finanger, Federica Alessi, Stefano Cazzaniga et autres
0 citationsNeuromuscular Disorders
682VPCharacterizing thrombocytopenia in patients with Duchenne muscular dystrophy treated with givinostat: results from the phase 3 EPIDYS trial
Laura McAdam, John F. Brandsema, Erika Finanger, Federica Alessi et autres
0 citationsNeuromuscular Disorders
651PLong-term safety of givinostat in patients with Duchenne muscular dystrophy: results from an open-label extension study
John F. Brandsema, Gyula Acsádi, N. Coceani, Federica Alessi et autres
1 citationNeuromuscular Disorders
688VPCharacterizing gastrointestinal adverse events of interest from a phase 3 study of givinostat in patients with Duchenne muscular dystrophy
L. De Waele, John F. Brandsema, Federica Alessi, Stefano Cazzaniga et autres
0 citationsNeuromuscular Disorders
680VPDisease progression modeling in Duchenne muscular dystrophy: delayed decay in 4-stair climb with givinostat compared with standard of care
C. Laverty, E. Mercuri, Federica Alessi, Simone Cazzaniga et autres
0 citationsNeuromuscular Disorders
661PGivinostat effect on respiratory function in Duchenne muscular dystrophy before and after ambulation loss: results from EPIDYS, LTSE, and PRO-DMD-01
Eugenio Mercuri, C. McDonald, C. Laverty, E. Finanger et autres
0 citationsNeuromuscular Disorders
Long‐Term Evaluation of Givinostat in Duchenne Muscular Dystrophy, and Natural History Comparisons
Craig M. McDonald, Michela Guglieri, Dragana Vučinić, Gyula Acsádi et autres
13 citationsAnnals of Clinical and Translational Neurology
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.